We are acutely aware of the importance of policy to realise real-world impact of our research. We engage with policy makers, NGOs, governmental control programme representatives and practitioners, both in the UK and those encountering NTDs in endemic countries. We achieve this in a variety of ways:

  • Dr Horton spoke at the Global Alliance for Rabies Control in Zurich, Switzerland in April 2018, a key international stakeholder meeting that influences government policy
  • Dr Simmonds is a member of the WHO Working Group on the Pathogenesis of Buruli ulcer, and attends the biennial WHO Global Buruli ulcer Initiative meeting. In 2017, her discovery of the pathogenic mechanism of the virulence toxin mycolactone was a key outcome of the meeting
  • Dr Kevin Maringer is an elected member of the Microbiology Society Policy Committee, which seeks to inform government policy through rational science